Avanza Fonder AB purchased a new position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 4,803 shares of the company's stock, valued at approximately $1,398,000.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Argent Capital Management LLC boosted its stake in shares of Molina Healthcare by 9.9% during the fourth quarter. Argent Capital Management LLC now owns 9,896 shares of the company's stock worth $2,880,000 after buying an additional 893 shares during the period. Tealwood Asset Management Inc. raised its stake in Molina Healthcare by 1.7% during the 4th quarter. Tealwood Asset Management Inc. now owns 4,612 shares of the company's stock valued at $1,342,000 after acquiring an additional 75 shares during the last quarter. Pallas Capital Advisors LLC lifted its position in Molina Healthcare by 132.9% during the 4th quarter. Pallas Capital Advisors LLC now owns 2,059 shares of the company's stock worth $599,000 after acquiring an additional 1,175 shares during the period. Czech National Bank grew its stake in shares of Molina Healthcare by 3.9% in the 4th quarter. Czech National Bank now owns 12,403 shares of the company's stock valued at $3,610,000 after purchasing an additional 466 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in shares of Molina Healthcare by 4.9% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 2,838 shares of the company's stock valued at $826,000 after purchasing an additional 132 shares during the period. 98.50% of the stock is owned by hedge funds and other institutional investors.
Molina Healthcare Price Performance
MOH stock traded up $3.76 during midday trading on Friday, hitting $286.36. 838,441 shares of the stock were exchanged, compared to its average volume of 426,981. The stock's 50-day moving average price is $296.84 and its 200-day moving average price is $317.13. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.55 and a current ratio of 1.54. The stock has a market cap of $16.38 billion, a price-to-earnings ratio of 14.54, a PEG ratio of 0.89 and a beta of 0.54. Molina Healthcare, Inc. has a fifty-two week low of $272.69 and a fifty-two week high of $423.92.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The company reported $6.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.96 by $0.05. Molina Healthcare had a return on equity of 27.88% and a net margin of 2.92%. The business had revenue of $10.34 billion during the quarter, compared to the consensus estimate of $9.92 billion. During the same quarter in the previous year, the company posted $5.05 EPS. The business's revenue was up 21.0% on a year-over-year basis. Research analysts predict that Molina Healthcare, Inc. will post 23.44 earnings per share for the current year.
Analysts Set New Price Targets
MOH has been the subject of several recent research reports. Wells Fargo & Company increased their price target on Molina Healthcare from $360.00 to $362.00 and gave the stock an "equal weight" rating in a report on Monday, November 4th. Barclays raised their target price on shares of Molina Healthcare from $359.00 to $372.00 and gave the stock an "equal weight" rating in a research note on Friday, October 25th. Cantor Fitzgerald reiterated an "overweight" rating and set a $406.00 price target on shares of Molina Healthcare in a research note on Thursday, October 24th. Robert W. Baird reduced their price objective on shares of Molina Healthcare from $405.00 to $331.00 and set an "outperform" rating for the company in a research report on Thursday, October 24th. Finally, Truist Financial dropped their target price on Molina Healthcare from $400.00 to $370.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Molina Healthcare has an average rating of "Hold" and a consensus target price of $359.18.
Check Out Our Latest Research Report on Molina Healthcare
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Recommended Stories
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.